Individuals are given three vaccinations at the 2 month National Immunisation Program Schedule point:

  • Infanrix hexa protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae type b and polio
  • Rotarix protects against rotavirus
  • Prevenar 13 protects against pneumococcal disease

AusVaxSafety has been conducting surveillance of the vaccines given at the 2 month Schedule point on a continuous basis since 2019. The analysis has remained constant over this time and not identified any safety concerns.

The latest medical attendance rate for the 2 month Schedule point is below and will be updated on a quarterly basis.


More detailed safety data from the 2 month Schedule point is available from the 2020 Vaccine Safety in Australia AusVaxSafety Summary Report below.

Click here to download AusVaxSafety data from the 2 month schedule point for 2020

Last updated December 2021